Generex Biotechnology Corporation

GNBT · OTC
Analyze with AI
$0.0006+$0.00 (+0%)
At close:Oct 27, 2022, 5:25 PM UTC
P/E TTM-0
P/B TTM-0
P/S TTM0
Dividend Yield0%
EPS-$0.373
Beta-0.062269
Valuation
PEG Ratio-0.00
FCF Yield–
EV / EBITDA-0.44
More On Valuation »
Quality
ROIC-88.91%
Gross Margin78.24%
Cash Conv. Ratio0.06
More On Quality »
Growth
Revenue 3Y CAGR55.83%
FCF Growth38.06%
More On Growth »
Safety
Net Debt / EBITDA-0.44
Interest Coverage-2.52
More On Safety »
Efficiency
Inventory Turnover0.78
Cash Conv. Cycle-14,559.25
More On Efficiency »

Generex Biotechnology Corporation (GNBT) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Generex Biotechnology Corporation (GNBT) stock price today?

As of Oct 27, 2022, 5:25 PM UTC, Generex Biotechnology Corporation (GNBT) stock is trading at $0.0006. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date GNBT stock quotes for informed trading decisions.

What is Generex Biotechnology Corporation's market capitalization?

Current market capitalization data for Generex Biotechnology Corporation (GNBT) is not available at this moment. Market cap depends on the latest share count and stock price from Financial Modeling Prep. This information typically updates after regulatory filings are processed.

What is the 52-week range for Generex Biotechnology Corporation stock?

Generex Biotechnology Corporation (GNBT) stock has traded in a 52-week range of $0.0001 — $0.1393. The 52-week range shows the highest and lowest prices at which GNBT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Generex Biotechnology Corporation stock price to this range provides context for recent price action.

How much trading volume does Generex Biotechnology Corporation stock have?

Generex Biotechnology Corporation (GNBT) stock recently traded approximately 1.1K shares. Trading volume indicates market liquidity and investor interest in GNBT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Generex Biotechnology Corporation stock.

Does Generex Biotechnology Corporation pay dividends to shareholders?

Yes, Generex Biotechnology Corporation (GNBT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Generex Biotechnology Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Generex Biotechnology Corporation's intraday price range?

Today, Generex Biotechnology Corporation (GNBT) stock has traded in a range of $0.0006 — $0.0006. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring GNBT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Generex Biotechnology Corporation stock data?

AlphaPilot sources real-time GNBT stock quotes, fundamental financial data, and historical price charts for Generex Biotechnology Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Generex Biotechnology Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of GNBT stock performance.